Genomic diagnostic, research and development

phix genomics
clinical diagnostic company

contributes to the improvement of the quality of life

About Us

PHIX GENOMICS is a clinical genomics diagnostic company, a corporation duly organized and existing under and by virtue of the laws of the Republic of the Philippines.
PHIX GENOMICS will offer, via its’ own lab facilities and via licensing agreements with established global leaders in clinical genomic diagnostics, a menu of tests including, but not limited to, Cancer profiling, Pharmacogenomics, New Born Screening, NIPD (non-invasive pregnancy diagnostic), Inherited Diseases, Infectious Diseses and Personal Genomics.  Working with Philippines’ medical professionals, PHIX GENOMICS will bring a new paradigm of health and prosperity to the Philippines.
Building on biomedical research programs, such as the Human Genome Project, and subsequent genomics research and development, PHIX GENOMICS will apply state-of-the-art genomics, bioinformatics and digital imaging technologies to generate the highest resolution, and most comprehensive diagnostic reporting.  Using this information, the company will empower healthcare professionals to accurately diagnose and treat disease, anticipate and stop disease, and guide safer therapeutic approaches. Through the application of these disruptive genomic technologies, the foundation for individualized precision medical treatment and personal health care is being layed. By representing the heart of a new paradigm of medicine that is evidence-based and rooted in quantitative science, PHIX Genomics contributes to the improvement of the quality of life for everyone in the Philippines (and beyond).
On the local front, PHIX GENOMICS will establish symbiotic relationships with key public institutions such as the Department of Science and Technology, Department of Health, National Institute of Health, Philippine Genome Center, World Health Organization, etc. Likewise, partnerships with academic and research institutions, as well as key medical institutions and medical associations will be cultivated and maintained. These networking activities will prove most useful as we proceed to develop our physician and consumer markets.
PHIX GENOMICS is founded and led by Mr. Jeffrey Seitz, currently Vice President of D-MARK Biosciences, Canada’s premier provider of advanced solutions for genomics and molecular biology. For the research and phase 1 development, he has formed a team with specialists in their respective fields

Executive Team

  • Jeffrey Seitz
    Jeffrey Seitz Chief Executive Officer
  • Fer Van Heijzen
    Fer Van Heijzen CHIEF FINANCIAL OFFICER
Contact Us

Feel free to ask questions.

Not readable? Change text. captcha txt